June 11 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX PROVIDES UPDATE ON RIZAPORT® VERSAFILM® NDA RESUBMISSION PROCESS FOLLOWING TYPE A MEETING WITH THE FDA
* INTELGENX TECHNOLOGIES CORP - OBTAINED CLARITY FROM FDA ON CMC INFORMATION REQUIRED FOR RESUBMISSION OF NDA FOR ACUTE MIGRAINES TREATMENT